-
12/21/2018
PAION announces submission of New Drug Application for remimazolam by its partner Mundipharma in Japan
-
11/16/2018
PAION announces that NMPA accepts submission of New Drug Application for remimazolam by Chinese licensee Yichang Humanwell
-
06/21/2018
PAION AG raises EUR 5.2 million in private placement